JPRN-UMIN000043313招募中未知
Imaging evaluation of estrogen receptor in breast cancer - Imaging evaluation of estrogen receptor in breast cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who received selective estrogen receptor modulators (SERMs) or selective estrogen down regulators (SERDs) within 5 weeks prior to [18F] FES-PET 2. Patient who had adverse reactions to [18F]FES in the past 3. Women who are or may be pregnant 4. Patients in extremely poor general condition 5. Patients with significant communication difficulties 6. Patients judged not to be appropriate for attending this study by investigators
研究者
相似试验
进行中（未招募）
1 期
Estrogen receptor and androgen receptor imaging in metastatic breast cancer patientsEUCTR2012-003981-42-NLniversity Medical Center Groningen
已完成
早期 1 期
Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor StatusBreast CancerNCT01916122Memorial Sloan Kettering Cancer Center54
已完成
2 期
Androgen receptor and estrogen receptor imaging in metastatic breast cancer patients10006291breast cancerNL-OMON39731niversitair Medisch Centrum Groningen20
已完成
2 期
AR and ER Imaging in Metastatic Breast CancerMetastatic Breast CancerNCT01988324University Medical Center Groningen24
已完成
2 期
Palbociclib and FES PETBreast CancerNCT02806050University Medical Center Groningen30